Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of personal protective equipment ensembles, incorporating powered air-purifying respirators protected from contamination, for the care of patients with high-consequence infectious diseases.
Crook B, Bailey C, Sykes A, Hoyle MC, Evans C, Poller B, Makison-Booth C, Pocock D, Tuudah C, Athan B, Hall S. Crook B, et al. Among authors: hoyle mc. J Hosp Infect. 2023 Apr;134:71-79. doi: 10.1016/j.jhin.2023.01.005. Epub 2023 Jan 27. J Hosp Infect. 2023. PMID: 36716796
Economic Evaluation of Three BRAF + MEK Inhibitors for the Treatment of Advanced Unresectable Melanoma With BRAF Mutation From a US Payer Perspective.
Halloush S, Alkhatib NS, Almutairi AR, Calamia M, Halawah H, Obeng-Kusi M, Hoyle M, Rashdan O, Koeller J, Abraham I. Halloush S, et al. Among authors: hoyle m. Ann Pharmacother. 2023 Sep;57(9):1016-1024. doi: 10.1177/10600280221146878. Epub 2023 Jan 13. Ann Pharmacother. 2023. PMID: 36639851 Clinical Trial.
Avelumab Plus Talazoparib in Patients With BRCA1/2- or ATM-Altered Advanced Solid Tumors: Results From JAVELIN BRCA/ATM, an Open-Label, Multicenter, Phase 2b, Tumor-Agnostic Trial.
Schram AM, Colombo N, Arrowsmith E, Narayan V, Yonemori K, Scambia G, Zelnak A, Bauer TM, Jin N, Ulahannan SV, Colleoni M, Aftimos P, Donoghue MTA, Rosen E, Rudneva VA, Telli ML, Domchek SM, Galsky MD, Hoyle M, Chappey C, Stewart R, Blake-Haskins JA, Yap TA. Schram AM, et al. Among authors: hoyle m. JAMA Oncol. 2023 Jan 1;9(1):29-39. doi: 10.1001/jamaoncol.2022.5218. JAMA Oncol. 2023. PMID: 36394867 Free PMC article.
113 results